Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
UCSF Seminar: "MRI of Lesion Development and Repair in Multiple Sclerosis"
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Multiple Sclerosis: An Update.
Gordon Research Conference on Notch Signaling in Development, Regeneration & Disease
Keystone Symposium: T Cells: Regulation and Effector Function
Avonex drug warning letter, severe hypatic injury
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Pages
« first
‹ previous
…
67
68
69
70
71
72
73
74
75
…
next ›
last »